Arkolith/Insider Trading/ANGN/Form 4

Venkatesan Jay

See Remarks, DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4 · filed May 25, 2022
Net Buying
Open-Market Buys
$101K
Open-Market Sells
$0
Net Open-Market Flow
$101K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 24, 2022Buy(P)32K$1.24$40K1.7M
May 20, 2022Buy(P)50K$1.23$62K1.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601485-22-000039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML